会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 41. 发明授权
    • 고체분산체 및 그 제조방법
    • 고체분산체및그제조방법
    • KR100676298B1
    • 2007-01-30
    • KR1020050078006
    • 2005-08-24
    • 씨제이 주식회사
    • 노현정김택로조청일고동현김태형서혜란조일환김창주
    • A61K31/4196
    • A solid dispersion is provided to show improved dissolution rate of a medicine, and improved stability of the dissolution rate according to passing of the storage time. The solid dispersion containing a compound represented by the formula(1) is prepared by dispersing a mixture consisting of a water-soluble polymer selected from the group consisting of poloxamer, polyethylene glycol, polyvinylpyrrolidone, copolymer of vinylpyrrolidone and vinyl acetate, and a mixture thereof, a surfactant having more than 10 of HLB, and the compound of the formula(1) in a strong disintegrating agent selected from the group consisting of crosscamellose sodium, sodium starch glycolate, crosspovidone, pre-gelatinized starch and a mixture thereof or a mixture consisting of the strong disintegrating agent and a pharmaceutically acceptable excipient. In the formula(1), R1 is C3-6 cycloalkyl, C3-6 cycloalkenyl, phenyl, C1-6 alkyl, C1-6 haloalky, C1-6 alkoxy, C1-6 haloalkoxy, phenyl substituted by at least one selected from the group consisting of halogen, amino, monoalkylamino, dialkylamino, nitro and cyano, styrenyl, C1-6 alkoxy styrenyl, and pyridyl, R2 is methyl or amino, and each A, B, C and D is independently C or N. Regarding the total weight of the dispersion, 0.1-10 wt.% of the water soluble polymer and 0.1-10 wt.% of the surfactant are contained.
    • 提供固体分散体以显示药物的溶解速率提高,并且随着储存时间的过去而改善溶解速率的稳定性。 含有由式(1)表示的化合物的固体分散体通过将由选自泊洛沙姆,聚乙二醇,聚乙烯吡咯烷酮,乙烯基吡咯烷酮和乙酸乙烯酯的共聚物及其混合物的水溶性聚合物组成的混合物 中,具有超过10的HLB的表面活性剂,和式(1)的在选自由crosscamellose钠,淀粉羟乙酸钠,交联聚维所组成的组中选择的强崩解剂的化合物中,预胶化淀粉和它们的混合物或混合物 由强力崩解剂和药学上可接受的赋形剂组成。 在式(1)中,R1是C3-6环烷基,C3-6环烯基,苯基,C1-6烷基,C1-6卤代烷基,C1-6烷氧基,C1-6卤代烷氧基,被选自 选自卤素,氨基,单烷基氨基,二烷基氨基,硝基和氰基,苯乙烯,C 1-6烷氧基苯乙烯基和吡啶基的基团,R 2是甲基或氨基,且每个A,B,C和d独立地是C或N.关于总 包含分散体的重量,0.1-10重量%的水溶性聚合物和0.1-10重量%的表面活性剂。
    • 42. 发明公开
    • 근채류 또는 과채류의 가공 식품 제조 방법
    • 制备根蔬菜或水果蔬菜加工食品的方法
    • KR1020070010664A
    • 2007-01-24
    • KR1020050065434
    • 2005-07-19
    • 씨제이 주식회사
    • 동명곤천희순최준봉
    • A23L1/212A23L1/214A23L1/218
    • A23L19/105A23L19/09A23L19/10
    • Provided is a method for preparing a processed food which exhibits a substantially improved conveniences of package and circulation, and has a regular size and thus is easy to produce an industrial product, and can be produced irrespective of season. The method comprises the steps of (i) heating a vegetable selected from the group consisting of root and fruit vegetables and immersing the vegetable into sugar liquid, (ii) forming the immersed vegetable into paste, (iii) forming the paste into original forms of the vegetables, (iv) applying or coating a material containing vegetable having color similar to that of peel of original fruit, on surface of the formed product of the step(iii), and (v) drying the applied or coated product. The root vegetables are selected from the group consisting of sweet potato, potato, and carrot. The fruit vegetables are selected from the group consisting of pumpkin and red pepper. The heating step(i) comprises immersing the vegetable in water of 90-100 deg.C for 10-40 minutes.
    • 本发明提供了一种制备加工食品的方法,其显示出包装和循环的显着改进的便利性,并且具有规则的尺寸,因此易于生产工业产品,并且可以生产而不考虑季节。 该方法包括以下步骤:(i)加热选自根和水果蔬菜的蔬菜并将植物浸入糖液中,(ii)将浸入的蔬菜形成糊状,(iii)将糊状物形成原始形式 蔬菜,(iv)在步骤(iii)的形成产品的表面上涂覆或涂覆含有与原始果实的果皮类似的植物的材料的材料,和(v)干燥所施加的或涂覆的产品。 根蔬菜选自甘薯,马铃薯和胡萝卜。 水果蔬菜选自南瓜和红辣椒。 加热步骤(i)包括将蔬菜浸入90-100℃的水中10-40分钟。
    • 48. 发明公开
    • 사람 과립구 콜로니 형성인자 동종체
    • 人造粒组织刺激因子
    • KR1020060129889A
    • 2006-12-18
    • KR1020050050608
    • 2005-06-13
    • 씨제이 주식회사
    • 고형곤
    • C07K14/535
    • A61K38/193A61K47/60
    • Human granulocyte-colony stimulating factor isoforms are provided to increase half life of the human granulocyte-colony stimulating factor in a living body without decrease of its activity. The human granulocyte-colony stimulating factor isoforms are provided, wherein at least one amino acid is added before threonine(Thr) of the N-terminal region or after proline(Pro) of the C-terminal region of human granulocyte-colony stimulating factor represented by the amino acid sequence of SEQ ID NO:1; and at least one amino acids added is cysteine and at least one cysteine is coupled with polyethylene glycol. A pharmaceutical composition comprises the human granulocyte-colony stimulating factor isoforms and pharmaceutically acceptable carriers. Genes encoding the human granulocyte-colony stimulating factor isoform proteins are provided.
    • 提供人粒细胞集落刺激因子同种型以增加人体中人粒细胞集落刺激因子的半衰期,而不降低其活性。 提供人粒细胞集落刺激因子同种型,其中在N末端区域的苏氨酸(Thr)之前或在人粒细胞集落刺激因子的C-末端区域的脯氨酸(Pro)之后加入至少一个氨基酸, 通过SEQ ID NO:1的氨基酸序列; 并且加入的至少一个氨基酸是半胱氨酸,并且至少一个半胱氨酸与聚乙二醇偶联。 药物组合物包含人粒细胞集落刺激因子同种型和药学上可接受的载体。 提供编码人粒细胞集落刺激因子同种型蛋白质的基因。